Alvine Pharmaceuticals
Alvine Pharmaceuticals develops novel therapies for autoimmune diseases.
Business Model:
Revenue: $8.5M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Alvine Pharmaceuticals Information
Geographic Data
Address: 75 Shoreway Rd
City: San Carlos
State: CA
Zip: 94070
Country: US
Financial Info
Stage:
debt financing
Raised Last:
$6M
Raised Total:$68M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Alvine Pharmaceuticals develops novel therapies for autoimmune diseases.
Contact Phone:
+16506321645
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2006 | Series A | 6 | $21.5M |
Panorama Capital InterWest Partners Prospect Venture Partners Flagship Pioneering Black River Asset Management Sofinnova Investments Sofinnova Investments Panorama Capital InterWest Partners Prospect Venture Partners Flagship Pioneering Black River Asset Management Sofinnova Investments Sofinnova Investments |
1/2013 | Debt Financing | $6M | 3/2011 | Venture Round | $26.5M | 9/2009 | Series A | $26.5M |
Panorama Capital InterWest Partners Prospect Venture Partners Sofinnova Ventures Black River Asset Management Flagship Ventures |
9/2006 | Series A | 2 | $8M |
Sofinnova Investments Prospect Venture Partners Prospect Venture Partners Sofinnova Investments Sofinnova Investments Prospect Venture Partners Prospect Venture Partners Sofinnova Investments |
12/2012 | Debt | $6M | 5/2013 | Unattributed | $70M |
AbbVie Inc. |
10/2011 | Debt | $6M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
